Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Numinus Wellness ( (TSE:NUMI) ) is now available.
Numinus Wellness Inc. has announced a leadership change with Michael Tan being appointed as the new CEO, while Payton Nyquvest transitions to Executive Chair. Tan, who has been with the company since 2019, will focus on enhancing clinical research and practitioner training programs to seize new opportunities in mental healthcare. Nyquvest will remain actively involved in shaping corporate strategy and fostering investor relations. The company also announced the resignation of Allen Morishita from its Board of Directors, acknowledging his contributions since its inception.
More about Numinus Wellness
Numinus Wellness Inc. is a mental healthcare company that focuses on innovative behavioral health treatments, including psychedelic-assisted therapies. The company is dedicated to integrating these therapies into mainstream clinical practice to address issues like depression, anxiety, trauma, pain, and substance use. Numinus offers technology-driven clinic support, clinical trial research, and comprehensive practitioner training, aiming to heal rather than merely manage symptoms.
YTD Price Performance: 12.50%
Average Trading Volume: 668,722
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$14.5M
For an in-depth examination of NUMI stock, go to TipRanks’ Stock Analysis page.
